Oppenheimer Reiterates Outperform on Addus HomeCare, Maintains $118 Price Target
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Michael Wiederhorn has reiterated an Outperform rating on Addus HomeCare (NASDAQ:ADUS) and maintained a $118 price target.
May 26, 2023 | 3:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer analyst Michael Wiederhorn reiterated an Outperform rating on Addus HomeCare (NASDAQ:ADUS) and maintained a $118 price target.
The reiteration of the Outperform rating and maintenance of the $118 price target by Oppenheimer analyst Michael Wiederhorn indicates a positive outlook for Addus HomeCare. This news is likely to have a positive impact on the stock price in the short term as it shows confidence in the company's performance and potential growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100